Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors

YU JIN KIM, SE-KYEONG JANG, GYEONGMI KIM, SUNG-EUN HONG, CHAN SUB PARK, MIN-KI SEONG, HYUN-AH KIM, KWANG SEOK KIM, CHUN-HO KIM, KI SOO PARK, JUNGIL HONG, HYEON-OK JIN and IN-CHUL PARK
Anticancer Research May 2023, 43 (5) 1973-1980; DOI: https://doi.org/10.21873/anticanres.16357
YU JIN KIM
1Division of Fusion Radiology Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
2Department of Biological Engineering, Konkuk University, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SE-KYEONG JANG
1Division of Fusion Radiology Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
3Department of Food and Microbial Technology, Seoul Women’s University, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GYEONGMI KIM
1Division of Fusion Radiology Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
4Department of Cosmetics Engineering, Konkuk University, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUNG-EUN HONG
5KIRAMS Radiation Biobank, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHAN SUB PARK
6Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIN-KI SEONG
6Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HYUN-AH KIM
6Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KWANG SEOK KIM
1Division of Fusion Radiology Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHUN-HO KIM
7Laboratory of Tissue Engineering, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KI SOO PARK
2Department of Biological Engineering, Konkuk University, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUNGIL HONG
3Department of Food and Microbial Technology, Seoul Women’s University, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HYEON-OK JIN
5KIRAMS Radiation Biobank, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IN-CHUL PARK
1Division of Fusion Radiology Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: parkic@kirams.re.kr
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 5 1973-1980
DOI 
https://doi.org/10.21873/anticanres.16357
PubMed 
37097659

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 1, 2023
  • Revision received March 7, 2023
  • Accepted March 8, 2023
  • Published online April 25, 2023.

Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. YU JIN KIM1,2,*,
  2. SE-KYEONG JANG1,3,*,
  3. GYEONGMI KIM1,4,
  4. SUNG-EUN HONG5,
  5. CHAN SUB PARK6,
  6. MIN-KI SEONG6,
  7. HYUN-AH KIM6,
  8. KWANG SEOK KIM1,
  9. CHUN-HO KIM7,
  10. KI SOO PARK2,
  11. JUNGIL HONG3,
  12. HYEON-OK JIN5 and
  13. IN-CHUL PARK1⇑
  1. 1Division of Fusion Radiology Research, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
  2. 2Department of Biological Engineering, Konkuk University, Seoul, Republic of Korea;
  3. 3Department of Food and Microbial Technology, Seoul Women’s University, Seoul, Republic of Korea;
  4. 4Department of Cosmetics Engineering, Konkuk University, Seoul, Republic of Korea;
  5. 5KIRAMS Radiation Biobank, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea;
  6. 6Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea;
  7. 7Laboratory of Tissue Engineering, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
  1. Correspondence to: In-Chul Park, Ph.D., Korea Institute of Radiological & Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea. Tel: +82 29701378, Fax: +82 29702455, e-mail: parkic{at}kirams.re.kr
  1. ↵* These Authors contributed equally to this work and are co-first authors.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Duloxetine enhances the sensitivity of non-small cell lung cancer cells to EGFR inhibitors by REDD1-induced mTORC1/S6K1 suppression
    Se-Kyeong Jang
    American Journal of Cancer Research 2024 14 3
  • Chromatin-modifying protein 4C (CHMP4C) affects breast cancer cell growth and doxorubicin resistance as a potential breast cancer therapeutic target
    Xiaoyan Jin, Jian Wang, Zhengyi Wang, Wenyang Pang, Yong Chen, Li Yang
    The Journal of Antibiotics 2024 77 2
  • Neurobiology of cancer: Adrenergic signaling and drug repurposing
    Zi-Kai Dong, Yong-Fei Wang, Wei-Ping Li, Wei-Lin Jin
    Pharmacology & Therapeutics 2024 264
  • Bemcentinib enhances sensitivity to estrogen receptor inhibitors in breast cancer cells
    Gyeongmi Kim, Se Hee Ahn, Se-Kyeong Jang, Selim Kim, Hyunggee Kim, Ki Soo Park, Hyeon-Ok Jin, Chan Sub Park, Min-Ki Seong, Hyun-Ah Kim, In-Chul Park
    The International Journal of Biochemistry & Cell Biology 2025 180
  • Identification and characterization of binding thermodynamics and kinetics of inhibitors targeting FGFR1 via molecular modelling and ligand Gaussian accelerated molecular dynamics simulations
    Subhasmita Mahapatra, Parimal Kar
    Physical Chemistry Chemical Physics 2025 27 19
  • Nebivolol Exerts Hepatoprotective Activity During CLP-Induced Sepsis by Modulating Oxidative Stress, Liver Regeneration, and AKT/MAPK Pathways in Rats
    Rahma Tharwat Sabra, Amany Abdlrehim Bekhit, Nourhan Tharwat Sabra, Nadia Ahmed Abd El-Moeze, Moustafa Fathy
    Stresses 2024 4 4
  • Stress regulatory hormones and cancer: the contribution of epinephrine and cancer therapeutic value of beta blockers
    Rajan Kumar Tiwari, Shiv Govind Rawat, Siddharth Rai, Ajay Kumar
    Endocrine 2025 88 2
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (5)
Anticancer Research
Vol. 43, Issue 5
May 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors
YU JIN KIM, SE-KYEONG JANG, GYEONGMI KIM, SUNG-EUN HONG, CHAN SUB PARK, MIN-KI SEONG, HYUN-AH KIM, KWANG SEOK KIM, CHUN-HO KIM, KI SOO PARK, JUNGIL HONG, HYEON-OK JIN, IN-CHUL PARK
Anticancer Research May 2023, 43 (5) 1973-1980; DOI: 10.21873/anticanres.16357

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Nebivolol Sensitizes BT-474 Breast Cancer Cells to FGFR Inhibitors
YU JIN KIM, SE-KYEONG JANG, GYEONGMI KIM, SUNG-EUN HONG, CHAN SUB PARK, MIN-KI SEONG, HYUN-AH KIM, KWANG SEOK KIM, CHUN-HO KIM, KI SOO PARK, JUNGIL HONG, HYEON-OK JIN, IN-CHUL PARK
Anticancer Research May 2023, 43 (5) 1973-1980; DOI: 10.21873/anticanres.16357
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Effects of Nebivolol-Gefitinib-Loratadine Against Lung Cancer Cell Lines
  • Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion
  • Google Scholar

More in this TOC Section

  • Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells
  • High Expression of OR1F1 Protein as a Potential Prognostic Biomarker for Esophageal Squamous Cell Carcinoma
  • Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer
Show more Experimental Studies

Similar Articles

Keywords

  • Akt
  • Breast cancer
  • combination therapy
  • FGFR
  • nebivolol
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire